ClinVar Miner

Submissions for variant NM_000091.5(COL4A3):c.4793T>G (p.Leu1598Arg) (rs752452590)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000665574 SCV000789720 likely pathogenic Alport syndrome, autosomal recessive 2017-02-14 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000665574 SCV000917259 likely pathogenic Alport syndrome, autosomal recessive 2019-07-01 criteria provided, single submitter clinical testing Variant summary: COL4A3 c.4793T>G (p.Leu1598Arg) results in a non-conservative amino acid change located in the Collagen IV, non-collagenous domain (IPR001442) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 5.6e-05 in 249436 control chromosomes (gnomAD). This frequency is not significantly higher than expected for a pathogenic variant in COL4A3 causing Alport Syndrome, autosomal recessive (5.6e-05 vs 0.002), allowing no conclusion about variant significance. c.4793T>G has been reported in the literature in at-least 5 individuals affected with autosomal recessive Alport Syndrome in compound heterozygosity (Oka_2014). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One other submitter has provided clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic.
Invitae RCV000821858 SCV000962630 pathogenic not provided 2020-08-20 criteria provided, single submitter clinical testing This sequence change replaces leucine with arginine at codon 1598 of the COL4A3 protein (p.Leu1598Arg). The leucine residue is highly conserved and there is a moderate physicochemical difference between leucine and arginine. This variant is present in population databases (rs752452590, ExAC 0.05%). This variant has been observed on the opposite chromosome (in trans) from other pathogenic variants in individuals affected with COL4A3-related conditions (PMID: 24633401). This finding is consistent with autosomal recessive inheritance, and suggests that this variant contributes to disease. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: Deleterious; PolyPhen-2: Probably Damaging; Align-GVGD: Class C0). For these reasons, this variant has been classified as Pathogenic.
Victorian Clinical Genetics Services,Murdoch Childrens Research Institute RCV001251486 SCV001427110 uncertain significance Alport syndrome 3, autosomal dominant 2018-05-15 criteria provided, single submitter clinical testing A heterozygous missense variant, NM_000091.4(COL4A3):c.4793T>G, has been identified in exon 51 of 52 of the COL4A3 gene. The variant is predicted to result in a major amino acid change from leucine to arginine at position 1598 of the protein (NP_000082.2(COL4A3):p.(Leu1598Arg)). The leucine residue at this position has very high conservation (100 vertebrates, UCSC), and is located within the C4 domain. In silico predictions for this variant are consistently pathogenic (Polyphen, SIFT, CADD, Mutation Taster). The variant is present in the gnomAD database at a frequency of 0.005% (0 homozygotes). This variant has not been previously reported in clinical cases. Based on the information available at the time of curation, this variant has been classified as VARIANT of UNCERTAIN SIGNIFICANCE (VUS).
Precision Medicine Center,Zhengzhou University RCV000665574 SCV001593071 uncertain significance Alport syndrome, autosomal recessive criteria provided, single submitter research PM1:Located in a mutational hot spot PM2:not found in gnomAD PP3:Multiple lines of computational evidence support a deleterious effect on the gene or gene product

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.